CRISPR THERAPEUTICS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.42 USD | +0.25% |
|
+6.17% | -8.67% |
| May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
| May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.95B | - | |||||
| 55.7B | - | |||||
| 39.91B | ||||||
| 39.57B | ||||||
| 28.16B | ||||||
| 26.3B |
